{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T12:28:07Z","timestamp":1782390487780,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ7004"],"award-info":[{"award-number":["2024JJ7004"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ7018"],"award-info":[{"award-number":["2024JJ7018"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clim.2025.110474","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:11:14Z","timestamp":1742422274000},"page":"110474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["An analysis of the clinical value of CHI3L1 as a biomarker of multiple myeloma progression"],"prefix":"10.1016","volume":"275","author":[{"given":"Langui","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110474_bb0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/BS9.0000000000000172","article-title":"Essential procedures of single-cell RNA sequencing in multiple myeloma and its translational value","volume":"5","author":"Du","year":"2023","journal-title":"Blood Sci."},{"key":"10.1016\/j.clim.2025.110474_bb0010","first-page":"12","article-title":"Exosomal miRNAs in the tumor microenvironment of multiple myeloma","author":"Alipoor","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.clim.2025.110474_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2022.102168","article-title":"Incidence of multiple myeloma in Kailuan cohort: a prospective community-based study in China","volume":"78","author":"Gao","year":"2022","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.clim.2025.110474_bb0020","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3389\/fonc.2019.01513","article-title":"Prevalence and incidence of multiple myeloma in urban area in China: a national population-based analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110474_bb0025","article-title":"Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110474_bb0030","article-title":"Active components of traditional Chinese medicinal material for multiple myeloma: current evidence and future directions","volume":"13","author":"Yu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.clim.2025.110474_bb0035","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1007\/s00277-024-05860-3","article-title":"Update on kidney injury caused by multiple myeloma","volume":"103","author":"Wang","year":"2024","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.clim.2025.110474_bb0040","first-page":"275","article-title":"Chimeric antigen receptor T-cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice","volume":"73","author":"Parikh","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clim.2025.110474_bb0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s12935-024-03425-y","article-title":"Uncovering novel mechanisms of chitinase-3-like protein 1 in driving inflammation-associated cancers","volume":"24","author":"Fan","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.clim.2025.110474_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.793835","article-title":"G721-0282 exerts anxiolytic-like effects on chronic unpredictable mild stress in mice through inhibition of Chitinase-3-like 1-mediated Neuroinflammation","volume":"16","author":"Ham","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.clim.2025.110474_bb0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.clim.2025.110474_bb0060","article-title":"CHI3L1 promotes proliferation and improves sensitivity to cetuximab in colon cancer cells by down-regulating p53","volume":"34","author":"Liu","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.clim.2025.110474_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/1878-0261.13138","article-title":"A small molecule targeting CHI3L1 inhibits lung metastasis by blocking IL-13R\u03b12-mediated JNK-AP-1 signals","volume":"16","author":"Lee","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.clim.2025.110474_bb0070","article-title":"Diagnostic and prognostic value of serum Chitinase 3-like protein 1 in hepatocellular carcinoma","volume":"36","author":"Wang","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.clim.2025.110474_bb0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/NHH.0000000000001249","article-title":"Multiple myeloma","volume":"42","author":"Vrtis","year":"2024","journal-title":"Home Healthc. Now"},{"key":"10.1016\/j.clim.2025.110474_bb0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1159\/000520504","article-title":"Current treatment approaches to newly diagnosed multiple myeloma","volume":"44","author":"Ghandili","year":"2021","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.clim.2025.110474_bb0095","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.hoc.2023.12.011","article-title":"Immune-pathogenesis of myeloma","volume":"38","author":"Dhodapkar","year":"2024","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.clim.2025.110474_bb0100","first-page":"10","article-title":"Inflammatory cytokines in cancer: comprehensive understanding and clinical progress in gene therapy","author":"Lan","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.clim.2025.110474_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.hoc.2023.12.010","article-title":"Molecular pathogenesis of multiple myeloma: clinical implications","volume":"38","author":"Maura","year":"2024","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.clim.2025.110474_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-020-00303-7","article-title":"Chitinase-3 like-protein-1 function and its role in diseases","volume":"5","author":"Zhao","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.clim.2025.110474_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-023-01131-9","article-title":"Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer","volume":"56","author":"Yu","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.clim.2025.110474_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33239-8","article-title":"CHI3L1 promotes tumor progression by activating TGF-\u03b2 signaling pathway in hepatocellular carcinoma","volume":"8","author":"Qiu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110474_bb0125","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2879.x","article-title":"Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells","volume":"77","author":"Mylin","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.clim.2025.110474_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1012889","article-title":"Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients","volume":"12","author":"Yan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110474_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.805702","article-title":"Development and validation of a novel prognostic model for overall survival in newly diagnosed multiple myeloma integrating tumor burden and comorbidities","volume":"12","author":"Jia","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.clim.2025.110474_bb0140","first-page":"192","article-title":"Expression level and clinical significance of VEGF, IL-17, \u03b22-MG and IL-35 in patients with multiple myeloma","volume":"26","author":"Jin","year":"2018","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.clim.2025.110474_bb0145","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.immuni.2021.07.002","article-title":"\u03b2(2)-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression","volume":"54","author":"Hofbauer","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110474_bb0150","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.clim.2025.110474_bb0155","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41390-021-01907-7","article-title":"Possible mechanism of CHI3L1 promoting tonsil lymphocytes proliferation in children with obstructive sleep apnea syndrome","volume":"91","author":"Wang","year":"2022","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.clim.2025.110474_bb0160","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3109\/10428194.2015.1004168","article-title":"Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma","volume":"56","author":"Mylin","year":"2015","journal-title":"Leuk. Lymphoma"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162500049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162500049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:37:29Z","timestamp":1762547849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162500049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":30,"alternative-id":["S152166162500049X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110474","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An analysis of the clinical value of CHI3L1 as a biomarker of multiple myeloma progression","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110474"}}